메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Meka, Phanni bhushann (Department of Genetics, Osmania University) Jarjapu, Sarika (Department of Genetics, Osmania University) Nanchari, Santhoshi Rani (Department of Genetics, Osmania University) Vishwakarma, Sandeep Kumar (Deccan College of Medical Sciences) Edathara, Prajitha Mohandas (Department of Genetics, Osmania University) Gorre, Manjula (Department of Genetics, Osmania University) Cingeetham, Anuradha (Department of Genetics, Osmania University) Vuree, Sugunakar (Department of Genetics, Osmania University) Annamaneni, Sandhya (Department of Genetics, Osmania University) Dunna, Nageswara Rao (School of Chemical & Biotechnology, Sastra University) Mukta, Srinivasulu (MNJ Institute of Oncology & Regional Cancer Centre) Triveni, B (MNJ Institute of Oncology & Regional Cancer Centre) Satti, Vishnupriya (Department of Genetics, Osmania University)
저널정보
아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제12호
발행연도
2015.1
수록면
4,965 - 4,969 (5page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
LCN2 (Lipocalin 2) is a 25 KD secreted acute phase protein, reported to be a novel regulator of angiogenesis in breast cancer. Up regulation of LCN2 had been observed in multiple cancers including breast cancer, pancreatic cancer and ovarian cancer. However, the role of LCN2 promoter methylation in the formation of microvessels is poorly understood. The aim of this study was to analyze the association of LCN 2 promoter methylation with microvessel formation and tumor cell proliferation in breast cancer patients. The LCN2 promoter methylation status was studied in 64 breast cancer tumors by methylation specific PCR (MSP). Evaluation of microvessel density (MVD) and Ki67 cell proliferation index was achieved by immunohistochemical staining using CD34 and MIB-1 antibodies, respectively. LCN2 promoter unmethylation status was observed in 43 (67.2%) of breast cancer patients whereas LCN2 methylation status was seen in 21 (32.8%). Further, LCN2 promoter unmethylation status was associated with aggressive tumor phenotype and elevated mean MVD in breast cancer patients.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0